The use of the thrombomimetics or cytokines; such as granulocyte colony-stimulating factor (G-CSF), is considered standard for ARS patients, to reduce neutropenia and thrombocytopenia [52]. However, the use of stem cell transplantation is an expert decision and is very limited, only for patients who have no other organ systems that will not recover [51,52]. This evidence concerns the gene CSF3 and Decreased total neutrophil count.